Q1 EPS Estimate for Corbus Pharmaceuticals Lifted by Analyst

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Free Report) – HC Wainwright boosted their Q1 2025 EPS estimates for shares of Corbus Pharmaceuticals in a research report issued to clients and investors on Wednesday, March 12th. HC Wainwright analyst A. Maldonado now anticipates that the biopharmaceutical company will post earnings per share of ($0.98) for the […]

Leave a Reply

Your email address will not be published.

Previous post Atb Cap Markets Weighs in on Cresco Labs Q1 Earnings
Next post Cellist Yo-Yo Ma and pianist Jon Kimura Parker among the guests for the Minnesota Orchestra’s summer and 2025-2026 seasons